Type 1, type 2, diabetes, MODY and LADA. How to make the differential diagnosis;Typ 1, typ 2 diabetes, MODY und LADA. So gelingt die differenzialdiagnose

MMW-Fortschritte der Medizin

Volumn 143, Issue 37, 2001, Pages 45-48

  Von Scherbaum, W A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; INSULIN;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; SHORT SURVEY;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0035855838     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables
2. Definition, klassifikation und diagnostik des diabetes mellitus
3. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40
4. Immunological heterogenity in type 1 diabetes: Presence of autoantibody patterns in patients with acute onset and slowly progressive disease
5. Autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of Insulin requirement in type 2 diabetes